Advanced Search
MyIDEAS: Login to save this paper or follow this series

Nya förutsättningar för svensk läkemedelsmarknad

Contents:

Author Info

  • Ekelund, Mats

    ()
    (Dept. of Economics, Stockholm School of Economics)

Registered author(s):

    Abstract

    Denna översikt över prissättning och konkurrens på läkemedelsmarknaden syftar till att översiktligt diskutera de nya förutsättningarna på den svenska läkemedelsmarknaden och implikationerna för hur vi i framtiden väljer att reglera läkemedelsmarknaden. Ett ökande kostnadsansvar för landsting och patienter gör att den svenska läkemedelsmarknaden allt mer börjar lika en normal marknad med kostnadskänsliga konsumenter. Detta innebär att såväl läkemedelsföretag som reglerande myndigheter bör ompröva sina respektive roller i prisbildningen. Läkemedelsbolagen måste inse att priset och inte bara kvaliteten är ett viktigt konkurrensmedel. Staten å sin sida bör se över i vilken utsträckning prisbildningen kan överlåtas till marknaden så att ett utrymme skapas för en sund konkurrenssituation.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://swopec.hhs.se/hastef/papers/hastef0404.pdf
    Download Restriction: no

    Bibliographic Info

    Paper provided by Stockholm School of Economics in its series Working Paper Series in Economics and Finance with number 404.

    as in new window
    Length: 36 pages
    Date of creation: 13 Oct 2000
    Date of revision:
    Handle: RePEc:hhs:hastef:0404

    Contact details of provider:
    Postal: The Economic Research Institute, Stockholm School of Economics, P.O. Box 6501, 113 83 Stockholm, Sweden
    Phone: +46-(0)8-736 90 00
    Fax: +46-(0)8-31 01 57
    Email:
    Web page: http://www.hhs.se/
    More information through EDIRC

    Related research

    Keywords: Prisreglering; läkemedel; Sverige; parallellimport; referenspriser.;

    Find related papers by JEL classification:

    This paper has been announced in the following NEP Reports:

    References

    No references listed on IDEAS
    You can help add them by filling out this form.

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:hhs:hastef:0404. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Helena Lundin).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.